|
Letter to the Editor: Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality
|
Jul 2020
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Effectiveness of azacitidine in higher-risk myelodysplastic syndromes
|
May 2016
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes
|
May 2014
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes
|
Mar 2015
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Evolution of NPM1-negative therapy-related myelodysplastic syndromes following curative treatment of NPM1-mutant AML
|
Jul 2017
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Epigenetics of myelodysplastic syndromes
|
Nov 2013
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
High-dose Romiplostim Accelerates Hematologic Recovery in Patients With Aplastic Anemia Refractory to Eltrombopag
|
Jul 2020
|
Leukemia
|
aplastic anemia
|
|
Myelodysplastic syndromes and the risk of cardiovascular disease in older adults: A SEER-medicare analysis
|
Dec 2019
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia
|
Feb 2013
|
Leukemia
|
aplastic anemia
|
|
Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
|
Nov 2013
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
